Evidence map›Paper›PMID 40272717›Full record

ArticleJournal of assisted reproduction and genetics2025

Scoping review on the embryonic developmental potential of tripronuclear zygotes and their use for clinical and research purposes.

Anne Mayeur, Khadija Ouaziz, Brian Sperelakis-Beedham, Paula Rubens, Nadine Gigarel, Julie Steffann, Nelly Frydman

Abstract readScoping Review
In one paragraph

Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anne Mayeur *Service de Biologie de La Reproduction-CECOS, Hôpital Antoine Béclère, AP-HP, 92140, Clamart, France. anne.mayeur@aphp.fr.ORCID http://orcid.org/0000-0002-5764-5382
Khadija Ouaziz *Service de Biologie de La Reproduction-CECOS, Hôpital Antoine Béclère, AP-HP, 92140, Clamart, France.
Brian Sperelakis-BeedhamInstitut Imagine INSERM UMR 1163, Et Service de Génétique Moléculaire, Université Paris Cité, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
Paula RubensInstitut Imagine INSERM UMR 1163, Et Service de Génétique Moléculaire, Université Paris Cité, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
Nadine GigarelInstitut Imagine INSERM UMR 1163, Et Service de Génétique Moléculaire, Université Paris Cité, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
Julie SteffannInstitut Imagine INSERM UMR 1163, Et Service de Génétique Moléculaire, Université Paris Cité, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
Nelly FrydmanService de Biologie de La Reproduction-CECOS, Hôpital Antoine Béclère, AP-HP, 92140, Clamart, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reviewed the published literature on human 3PN zygotes, focusing on their developmental potential, genetic status, and possible correction, either spontaneous (autocorrection) or through micromanipulation. A total of 29 articles published between 2000 and 2023 were deemed eligible for this scoping review. Significant differences exist between the developmental potential of bipronucleated zygotes and 3PN zygotes, with the latter showing a lower blastulation rate and altered cleavage patterns, and this is related to the fertilization method used. 3PN embryos obtained by conventional IVF are most often diandric, and arrest their development more quickly with a lower blastulation rate, compared to those obtained by ICSI. This result may be linked to the number of centrioles establishing the first cytokinesis. Autocorrection can occur in 3PN zygotes, resulting in diploid embryos, and there have been reports of live births following the transfer of 3PN embryos. Induced diploidization through pronuclear removal by micromanipulation is technically feasible and associated with good survival rates. Because tripronuclear embryos are destined to be discarded, they can serve as a source of additional embryos for research purposes without major ethical concerns. Furthermore, the transfer of 3PN embryos, corrected either spontaneously or by micromanipulation, holds the potential to increase the pool of embryos eligible for transfer in IVF centers. However, this cannot be considered without genetic screening aiming to evaluate diploidy, euploidy, and heteroparental inheritance, and no studies have yet evaluated these three genetic aspects comprehensively. Further research is essential to fully understand the physiology and potential of corrected 3PN zygotes in the fields of assisted reproduction and research.

Indexed as

Embryonic DevelopmentZygoteEmbryo TransferFemaleFertilization in VitroHumansPregnancySperm Injections, IntracytoplasmicAbnormal fertilizationCorrected 3PNTripronuclear developmentTripronuclear geneticsTripronuclear zygotes

Identifiers

PMID40272717
PMCPMC12229291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.